Tag: ETR

Finance

Stocks in Focus : BIND Therapeutics (NASDAQ:BIND), Bristol-Myers Squibb (NYSE:BMY), TC PipeLines (NYSE:TCP), Entergy Corporation (NYSE:ETR), Rigel Pharmaceuticals (NASDAQ:RIGL)

BIND Therapeutics, Inc. (NASDAQ: BIND), a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called AccurinsTM, today announced the appointments of Eric K. Rowinsky, M.D. and Amy W. Schulman to the company’s board of directors. Together the significant insights and expertise of these two industry leaders will help to guide BIND’s management team in the achievement of its business and development goals. BIND Therapeutics, … Continue reading Stocks in Focus : BIND Therapeutics (NASDAQ:BIND), Bristol-Myers Squibb (NYSE:BMY), TC PipeLines (NYSE:TCP), Entergy Corporation (NYSE:ETR), Rigel Pharmaceuticals (NASDAQ:RIGL)

Jayne Crisman
Finance

Stocks in Focus: BIND Therapeutics, Inc. (NASDAQ:BIND), Bristol-Myers Squibb Company (NYSE:BMY), TC PipeLines, LP (NYSE:TCP), Entergy Corporation (NYSE:ETR), Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)

BIND Therapeutics, Inc. (NASDAQ: BIND), a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called AccurinsTM, today announced the appointments of Eric K. Rowinsky, M.D. and Amy W. Schulman to the company’s board of directors. Together the significant insights and expertise of these two industry leaders will help to guide BIND’s management team in the achievement of its business and development goals. BIND Therapeutics, … Continue reading Stocks in Focus: BIND Therapeutics, Inc. (NASDAQ:BIND), Bristol-Myers Squibb Company (NYSE:BMY), TC PipeLines, LP (NYSE:TCP), Entergy Corporation (NYSE:ETR), Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)

Kristen Barton
Finance

Investors Watch List : Merck & Co (NYSE:MRK), Activision Blizzard (NASDAQ:ATVI), Brooks Automation (NASDAQ:BRKS), Entergy Corporation (NYSE:ETR), CytRx Corporation (NASDAQ:CYTR)

Merck & Co. Inc. (NYSE:MRK) has been sued by Bristol-Myers Squibb Co (BMY) and Ono Pharmaceutical Co., Ltd. (Japan) (OPHLY) for patent infringement of Bristol-Myers’ novel PD-1 inhibitor, Optivo. Merck recently won the US Food and Drug Administration’s (FDA) approval for its own PD-1 drug, Keytruda. This made the company the first one to enter the US immunotherapy market, which is expected to reach $35 … Continue reading Investors Watch List : Merck & Co (NYSE:MRK), Activision Blizzard (NASDAQ:ATVI), Brooks Automation (NASDAQ:BRKS), Entergy Corporation (NYSE:ETR), CytRx Corporation (NASDAQ:CYTR)

Chris Lewis
Finance

NSYE Overbought Stocks: Exelon Corporation (NYSE:EXC), Goodrich Petroleum Corporation (NYSE:GDP), Entergy Corporation (NYSE:ETR), Aspen Insurance Holdings (NYSE:AHL)

Exelon Corporation (NYSE:EXC)’s stock had its “outperform” rating reaffirmed by analysts at Credit Suisse in a research report issued to clients and investors on Tuesday. Exelon Corporation (NYSE:EXC) stock performance was 2.01% in last session and finished the day at $36.00. Traded volume was 7.26million shares in the last session and the average volume of the stock remained 7.45million shares. The beta of the stock … Continue reading NSYE Overbought Stocks: Exelon Corporation (NYSE:EXC), Goodrich Petroleum Corporation (NYSE:GDP), Entergy Corporation (NYSE:ETR), Aspen Insurance Holdings (NYSE:AHL)

Colin Pettis
Finance

Why Trader’s Are Watching: Curis, Inc. (NASDAQ:CRIS), BlackBerry Ltd (NASDAQ:BBRY), Goldfield Corp. (NYSEMKT:GV), Entergy Corporation (NYSE:ETR), Las Vegas Sands Corp. (NYSE:LVS)

On Dec. 18, Curis, Inc. (NASDAQ:CRIS) announced that the first patient has initiated treatment with CUDC-907 in a Phase 1 clinical trial in patients with advanced or relapsed solid tumors, including hormone receptor positive (HR+)/ HER2-negative breast cancer or midline carcinoma with certain NUT gene rearrangements. CUDC-907 is an oral, dual inhibitor of histone deacetylase (HDAC) and phosphoinositide 3-kinase (PI3K) enzymes that is currently under … Continue reading Why Trader’s Are Watching: Curis, Inc. (NASDAQ:CRIS), BlackBerry Ltd (NASDAQ:BBRY), Goldfield Corp. (NYSEMKT:GV), Entergy Corporation (NYSE:ETR), Las Vegas Sands Corp. (NYSE:LVS)

Kristen Barton